Search
Search results
148 results found
Aging
Coming soon
Alcoholic Hepatitis: A Review.
Hosseini, Nooshin, Julia Shor, and Gyongyi Szabo. 2019. “Alcoholic Hepatitis: A Review.”. Alcohol and Alcoholism (Oxford, Oxfordshire) 54 (4): 408-16.
Dysregulated Autophagy and Lysosome Function Are Linked to Exosome Production by Micro-RNA 155 in Alcoholic Liver Disease.
Babuta, Mrigya, Istvan Furi, Shashi Bala, Terence N Bukong, Patrick Lowe, Donna Catalano, Charles Calenda, Karen Kodys, and Gyongyi Szabo. 2019. “Dysregulated Autophagy and Lysosome Function Are Linked to Exosome Production by Micro-RNA 155 in Alcoholic Liver Disease.”. Hepatology (Baltimore, Md.) 70 (6): 2123-41.
Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease.
Lucey, Michael Ronan, Gene Y Im, Jessica L Mellinger, Gyongyi Szabo, and David W Crabb. 2020. “Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease.”. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 26 (1): 14-16.
Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.
Crabb, David W, Gene Y Im, Gyongyi Szabo, Jessica L Mellinger, and Michael R Lucey. 2020. “Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.”. Hepatology (Baltimore, Md.) 71 (1): 306-33.
Sarcopenia is associated with longer hospital stay and multiorgan dysfunction in alcoholic hepatitis.
Al-Azzawi, Yasir, Betty Albo, Matthew Fasullo, Jennifer Coukos, George J Watts, Ryan Tai, David Radcliffe, Aimee Kroll-Desrosiers, Deepika Devuni, and Gyongyi Szabo. 2020. “Sarcopenia Is Associated With Longer Hospital Stay and Multiorgan Dysfunction in Alcoholic Hepatitis.”. European Journal of Gastroenterology & Hepatology 32 (6): 733-38.
Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.
Dasarathy, Srinivasan, Mack C Mitchell, Bruce Barton, Craig J McClain, Gyongyi Szabo, Laura E Nagy, Svetlana Radaeva, and Arthur J McCullough. 2020. “Design and Rationale of a Multicenter Defeat Alcoholic Steatohepatitis Trial: (DASH) Randomized Clinical Trial to Treat Alcohol-Associated Hepatitis.”. Contemporary Clinical Trials 96: 106094.
Emerging medical therapies for severe alcoholic hepatitis.
Tornai, David, and Gyongyi Szabo. 2020. “Emerging Medical Therapies for Severe Alcoholic Hepatitis.”. Clinical and Molecular Hepatology 26 (4): 686-96.
Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans.
Miyata, Tatsunori, Xiaoqin Wu, Xiude Fan, Emily Huang, Carlos Sanz-Garcia, Christina K Cajigas-Du Ross, Sanjoy Roychowdhury, et al. 2021. “Differential Role of MLKL in Alcohol-Associated and Non-Alcohol-Associated Fatty Liver Diseases in Mice and Humans.”. JCI Insight 6 (4).